tiprankstipranks
Trending News
More News >
CellaVision AB (SE:CEVI)
:CEVI
Sweden Market
Advertisement

CellaVision AB (CEVI) Stock Forecast & Price Target

Compare
1 Followers
See the Price Targets and Ratings of:

CEVI Financial Forecast

CEVI Earnings Forecast

Next quarter’s earnings estimate for CEVI is kr1.52 with a range of kr1.50 to kr1.57. The previous quarter’s EPS was kr1.60. CEVI beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.11% of the time in the same period. In the last calendar year CEVI has Outperformed its overall industry.
Next quarter’s earnings estimate for CEVI is kr1.52 with a range of kr1.50 to kr1.57. The previous quarter’s EPS was kr1.60. CEVI beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.11% of the time in the same period. In the last calendar year CEVI has Outperformed its overall industry.

CEVI Sales Forecast

Next quarter’s sales forecast for CEVI is kr187.00M with a range of kr183.00M to kr190.50M. The previous quarter’s sales results were kr191.33M. CEVI beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 47.08% of the time in the same period. In the last calendar year CEVI has Outperformed its overall industry.
Next quarter’s sales forecast for CEVI is kr187.00M with a range of kr183.00M to kr190.50M. The previous quarter’s sales results were kr191.33M. CEVI beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 47.08% of the time in the same period. In the last calendar year CEVI has Outperformed its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on SE:CEVI
TipRanks AITipRanks
Not Ranked
TipRanks
kr187
Hold
9.61%
Upside
Downgraded
07/22/25
CellaVision AB's strong financial health and profitability are significant strengths, positioning it well in the Medical Devices industry. However, bearish technical indicators and a moderate valuation suggest caution in the short term.
AI Firm
kr215kr207
Buy
21.34%
Upside
Reiterated
06/14/25
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on SE:CEVI
TipRanks AITipRanks
Not Ranked
TipRanks
kr187
Hold
9.61%
Upside
Downgraded
07/22/25
CellaVision AB's strong financial health and profitability are significant strengths, positioning it well in the Medical Devices industry. However, bearish technical indicators and a moderate valuation suggest caution in the short term.
AI Firm
kr215kr207
Buy
21.34%
Upside
Reiterated
06/14/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering CellaVision AB

1 Month
xxx
Success Rate
0/2 ratings generated profit
0%
Average Return
0.00%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.
3 Months
xxx
Success Rate
0/2 ratings generated profit
0%
Average Return
0.00%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.
1 Year
Success Rate
0/2 ratings generated profit
0%
Average Return
0.00%
reiterated a buy rating 2 months ago
Copying Lila Implantra's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.
2 Years
xxx
Success Rate
0/2 ratings generated profit
0%
Average Return
0.00%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CEVI Analyst Recommendation Trends

Rating
Jan 24
Apr 24
May 25
Jun 25
Jul 25
Strong Buy
1
2
2
3
2
Buy
0
0
0
0
0
Hold
2
2
2
2
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
4
4
5
7
In the current month, CEVI has received 2 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. CEVI average Analyst price target in the past 3 months is 206.99.
Each month's total comprises the sum of three months' worth of ratings.

CEVI Stock Forecast FAQ

What is SE:CEVI’s average 12-month price target, according to analysts?
Based on analyst ratings, CellaVision AB’s 12-month average price target is 206.99.
    What is SE:CEVI’s upside potential, based on the analysts’ average price target?
    CellaVision AB has 21.33% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is CellaVision AB a Buy, Sell or Hold?
          CellaVision AB has a consensus rating of Moderate Buy, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is CellaVision AB’s share price target?
            The average share price target for CellaVision AB is 206.99. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is kr206.99 ,and the lowest forecast is kr206.99. The average share price target represents 21.33% Increase from the current price of kr170.6.
              What do analysts say about CellaVision AB?
              CellaVision AB’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of CellaVision AB?
                To buy shares of SE:CEVI, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis